Monoclonal antibody discovery mice

Trianni has developed transgenic immunoglobulin mice capable of expressing the full human antibody repertoire, ideal for the discovery of new therapeutic antibody candidates.

Like Comment
Page of
Go to the profile of Trianni


Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. Our existing asset is a cutting-edge platform enabling efficient discovery of fully-human monoclonal antibodies.

No comments yet.